No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for GENMAB A/S in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
PB
Paradigm Biocapital Advisors LP
|
13.1M | 20.29% | +5.2M (+64.8%) | Q3 '25 | 6.8% | |
|
Shares held by quarter
Peak holding13.1M (Q2'26)
Change over 8 quarters+13.1M
Share of the company20.290%
|
||||||
|
OA
Orbis Allan Gray Ltd
|
11.4M | 17.56% | −1.6M (−12.0%) | 2024 | 1.1% | |
|
Shares held by quarter
Peak holding14.4M (Q4'25)
Change over 8 quarters+9.7M
Share of the company17.560%
|
||||||
28 more super investors behind a free account
See every manager holding GENMAB A/S, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
HL
Harding Loevner Funds Inc
|
$134M | 466.8K | 0.72% | 1.06% | July 31, 2026 |
|
IB
iShares Trust
|
$102M | 3.7M | 5.72% | 1.12% | June 30, 2026 |
23 more funds behind a free account
See every fund holding GENMAB A/S and how much of the fund the position is.
Sign up freeLoading...